Visual Performance With a Trifocal Intraocular Lens
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01605058|
Recruitment Status : Unknown
Verified May 2012 by Elizabeth Agrippa, BMI Southend Hospital.
Recruitment status was: Not yet recruiting
First Posted : May 24, 2012
Last Update Posted : May 30, 2012
The purpose of this study is to evaluate the visual performance of a trifocal intraocular lens at distance, near and intermediate viewing, by way of visual acuity measurement, contrast sensitivity.
Patient satisfaction and quality of vision will also be assessed by way of a questionnaire.
|Condition or disease|
Monocular and Binocular Unaided (UCVA) and Best Corrected Visual Acuity (BCVA) will be measured at 6m in LogMAR units under photopic conditions (85cd/m2).
Subjective Refraction will be performed to establish any residual refractive error will for distance, intermediate and near.
Defocus Profiles (visual acuity over imposed defocus) are measured for each patient. The patient observes the 6m LogMAR chart through best distance correction, then defocusing is achieved by the addition of pairs of lenses from +2.00D to -4.00D in 0.50D steps.. The LogMAR acuity will be recorded and the data plotted.
Contrast Sensitivity will be evaluated monocularly under photopic (85cd/m2) conditions and mesopic (4cd/m2) using the Pelli-Robson Contrast Sensitivity Chart.
Near and intermediate performance will be evaluated using the Radner Reading Charts to assess acuity (LogRAD units) and reading speed in photopic conditions 85cd/m2
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Visual Performance Adn Quality of Vision Evaluation After Implantation of a Trifocal Intraocular Lens|
|Study Start Date :||June 2012|
|Estimated Primary Completion Date :||July 2013|
|Estimated Study Completion Date :||August 2013|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01605058
|BMI Southend Hospital||Not yet recruiting|
|Westclifff-on-Sea, Essex, United Kingdom, SS0 9AG|
|Contact: Elizabeth Agrippa 07795176257 firstname.lastname@example.org|
|Principal Investigator:||Elizabeth M Agrippa, BSc||BMI Southend|